These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32103369)

  • 1. Cryo-imaging of Stem Cell Biodistribution in Mouse Model of Graft-Versus-Host-Disease.
    Wuttisarnwattana P; Eid S; Gargesha M; Cooke KR; Wilson DL
    Ann Biomed Eng; 2020 Jun; 48(6):1702-1711. PubMed ID: 32103369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of therapeutic role of mesenchymal stromal cells in mouse models of graft-versus-host disease using cryo-imaging.
    Wuttisarnwattana P; Eid S; Wilson DL; Cooke KR
    Sci Rep; 2023 Jan; 13(1):1698. PubMed ID: 36717650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.
    Auletta JJ; Eid SK; Wuttisarnwattana P; Silva I; Metheny L; Keller MD; Guardia-Wolff R; Liu C; Wang F; Bowen T; Lee Z; Solchaga LA; Ganguly S; Tyler M; Wilson DL; Cooke KR
    Stem Cells; 2015 Feb; 33(2):601-14. PubMed ID: 25336340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Route of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation.
    Wang F; Eid S; Dennis JE; Cooke KR; Auletta JJ; Lee Z
    J Stem Cells Regen Med; 2015; 11(2):34-43. PubMed ID: 27330253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and Clearance of Human Mesenchymal Stem Cells by Quantitative Three-Dimensional Cryo-Imaging After Intravenous Infusion in a Rat Lung Injury Model.
    Schmuck EG; Koch JM; Centanni JM; Hacker TA; Braun RK; Eldridge M; Hei DJ; Hematti P; Raval AN
    Stem Cells Transl Med; 2016 Dec; 5(12):1668-1675. PubMed ID: 27460855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
    Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
    Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models.
    Nishi Y; Murakami A; Murayama Y; Tsukahara N; Okamoto S; Nakachi S; Morichika K; Tamaki K; Noguchi H; Matsushita M; Karube KN; Fukushima T; Morishima S; Kishimoto H; Masuzaki H
    Transpl Immunol; 2019 Aug; 55():101205. PubMed ID: 30946889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
    Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
    Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
    Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
    Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioimaging for the monitoring of the in vivo distribution of infused mesenchymal stem cells in a mouse model of the graft-versus-host reaction.
    Joo SY; Cho KA; Jung YJ; Kim HS; Park SY; Choi YB; Hong KM; Woo SY; Seoh JY; Ryu KH
    Cell Biol Int; 2011 Apr; 35(4):417-21. PubMed ID: 21062262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
    Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models].
    Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease.
    Tang B; Li X; Liu Y; Chen X; Li X; Chu Y; Zhu H; Liu W; Xu F; Zhou F; Zhang Y
    Cell Physiol Biochem; 2018; 46(6):2624-2635. PubMed ID: 29763906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.